Sartorius stock pre-market: EUR 248.80, prior close EUR 248.65
Published on 10/09/2026 at 07:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Sartorius traded at EUR 248.80 pre-market at Lang & Schwarz.
- The prior close was EUR 248.65 on October 8, 2026.
- Results are scheduled for October 22, 2026; RBC's target is EUR 220.00.
At 7:30 a.m. CEST on October 9, 2026, Sartorius stock was at EUR 248.80 pre-market at Lang & Schwarz, up 0.06 percent versus the prior close of EUR 248.65 on October 8, 2026.
Pre-market trading
Lang & Schwarz showed a bid of EUR 247.10 and an ask of EUR 250.50. The quote was only marginally above the previous session's reference level, leaving the stock close to unchanged ahead of the Xetra open. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Sartorius stock.
What matters today
Sartorius is scheduled to report its latest quarterly results on October 22, 2026. A move to EUR 250.00 would represent a distance of 0.48 percent from the pre-market price of EUR 248.80. RBC maintained a Sector Perform rating and a EUR 220.00 price target in an analysis dated October 6, 2026, according to dpa-AFX reporting carried by FinanzNachrichten.de.
Analyst view
The report said RBC's analyst Charles Weston adjusted the valuation model for Sartorius and its French subsidiary Sartorius Stedim Biotech to reflect returned U.S. tariffs, the Mattek acquisition and currency movements. The report described the effect on 2026 revenue forecasts as minimal and the impact in subsequent years as moderately positive.
Market context: Market report DAX.
